Non-peptide GLP-1 agonists

Details Non-peptide GLP-1 agonists Non-peptide GLP-1 agonists

2005-08-09

2005-08-09

Raymond, Richard L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S249000, C544S335000, C544S349000, C544S353000, C544S354000, C544S355000, C544S356000

Reexamination Certificate

active

06927214

ABSTRACT:
Novel non-peptide GLP-1 agonists, pharmaceutical compositions comprising them, use of the non-peptide GLP-1 agonists for the preparation of pharmaceutical compositions and methods for the treatment and/or prevention of disorders and diseases wherein an activation of the human GLP-1 receptor is beneficial, especially metabolic disorders such as IGT, Type 1 diabetes, Type 2 diabetes and obesity.

REFERENCES:
patent: 4022777 (1977-05-01), Sam et al.
patent: 4200748 (1980-04-01), Wright, Jr. et al.
patent: 4349674 (1982-09-01), Freed, deceased et al.
patent: 5849742 (1998-12-01), App et al.
patent: 3 826 603 (1990-02-01), None
patent: 0 018 493 (1980-11-01), None
patent: 0 216 299 (1987-04-01), None
patent: 0 277 794 (1988-08-01), None
patent: 0 338 346 (1989-10-01), None
patent: 1 469 360 (1967-01-01), None
patent: 966818 (1964-08-01), None
patent: 55167205 (1980-12-01), None
patent: WO 87/06941 (1987-11-01), None
patent: WO 90/11296 (1990-10-01), None
patent: WO 91/11457 (1991-08-01), None
patent: WO 95/05378 (1995-02-01), None
patent: WO 95/24403 (1995-09-01), None
patent: WO 96/30370 (1996-10-01), None
patent: 9719934 (1997-06-01), None
patent: WO 97/32858 (1997-09-01), None
patent: WO 98/20895 (1998-05-01), None
patent: WO 98/28414 (1998-07-01), None
patent: WO 98/52945 (1998-11-01), None
patent: WO 99/01423 (1999-01-01), None
patent: WO 99/01442 (1999-01-01), None
Wozniak et al, Indian J. od Heterocyclic Chem. 4/2,75080(1994).
Englehardt et al, DE 2433397,Feb, 1975, also cited as Chemical Abstract DN 82:156377.
Page et al, ACS, Inorganic Chem. 37/17/4452-4459(1998).
Chemical Abstract DN 122:314514, Wozniak et al, also cited as Indian J. Heterocyclic Chem. 4/2.75-80(1994).
Chemical Abstract DN 103:37081 for CASRN 97183-62-5.
Chemical Abstract DN 92:76440 for CASRN # 52312-40-0.
Chemical Abstract DN117:192207 for CASRN# 143309087-9P.
Chemical Abstract DN 75:129758 for CASRN # 33870-76-7P/7, 33870-77-8.
Chemical Abstract DN 109:92044 for CASRN # 6640-47-7,90004-55-0P.
Chemical AbstractDN 115:70795 for CASRN # 34972-22-0.
Chemical Abstract DN 128:75375 for CASRN#6640-47-7, 200815-10-7P.
Chemical Abstract DN 82:156377, also cited as Englehardt et al, DE 2433397, Feb. 1975.
Chemical Abstract DN 129:224913, also cited as Page et.al, ACS, Inorganic Chem., 37/17/4452-4459(1998).
Chemical Abstract DN 112:179028, also cited as JP 01261389, dated Oct. 1989.
Chung et al, Chem. Commun. “Quinoxalino-fused sultines and their Application in Diels-Alder reactions” pp. 205-206 (1997).
J. J. Holst, Annu. Rev. Physiol., vol. 59, pp. 257-271 (1997).
Nauck et al., J. Clin. Invest., vol. 91, pp. 301-307 (1993).
Qualmann et al., Acta Diabetol., vol. 32, pp. 13-16 (1995).
Nathan, M.D. et al., Diabetes Care, vol. 15, pp. 270-276 (1992).
Nauck et al., Diabetologia, vol. 36, pp. 741-744 (1993).
Kreymann et al., The Lancet, pp. 1300-1304, Dec. 5, 1987.
Rachman et al., Diabetologia, vol. 40, pp. 205-211 (1997).
Gutniak, M. D., Ph. D. et al., Diabetes Care, vol. 17, pp. 1039-1044 (1994).
Nauck et al., Diabetologia, vol. 39, pp. 1546-1553 (1996).
Creutzfeldt, M.D., F.R.C.P. et al., Diabetes Care, vol. 19, pp. 580-586 (1996).
Fehmann et al., Endocrinology, vol. 130, pp. 159-166 (1992).
Wang et al., Endocrinology, vol. 136, pp. 4910-4917 (1995).
Wang et al., The Journal of Clinical Investigation, vol. 99, pp. 2883-2889 (1997).
Edvell et al., Endocrinology, vol. 140, pp. 778-783 (1999).
Buteau et al., Diabetologia, vol. 42, pp. 856-864 (1999).
Xu et al., Diabetes, vol. 48, pp. 2270-2276 (1999).
Nauck et al., Diabetologia, vol. 29, pp. 46-52 (1986).
Holst et al., Diabetologia, vol. 40, pp. 984-986 (1997).
Flint et al., J. Clin. Invest., vol. 101, pp. 515-520 (1998).
Naslund et al., Drug News Perspect, vol. 11, pp. 92-97 (1998).
Ranganath et al., Gut, vol. 38, pp. 916-919 (1996).
Naslund et al., Digestive Diseases and Sciences, vol. 43, pp. 945-952 (1998).
Naslund et al., Am J Clin Nutr, vol. 68, pp. 525-530 (1998).
Deacon et al., Diabetes, vol. 44, pp. 1126-1131 (1995).
Knudsen et al., European Journal of Pharmacology, vol. 318, pp. 429-435 (1996).
Horn et al., Receptors and Channels, vol. 5, pp. 305-314 (1998).
Adelhorst et al., The Journal of Biological Chemistry, vol. 269, No. 9, pp. 6275-6278 (1994).
Mechanism et al., The Journal of Biological Chemistry, vol. 273, No. 29, pp. 17979-17982 (1998).
Willms et al., Journal of Clinical Endocrinology and Metabolism, vol. 81, No. 1, pp. 327-332 (1996).
Makino et al., Heterocycles, vol. 26, pp. 1215-1220 (1987).
Abstract of Iijima et al., Yakugaku Zasshi, vol. 108, No. 5, pp. 437-442 (1988).
Abstract of Cascieri et al., J. Biol. Chem., vol. 274, No. 13, pp. 8694-8697 (1999).
Abstract of O.S. Moustafa, Phosphorus, Sulfur Silicon Relat. Elem., vol. 131, pp. 49-57 (1997).
Abstract of Guillon et al., Pharm. Pharmacol. Commun., vol. 4, No. 7, pp., 319-324 (1998).
Abstract of Tomoda et al., Bull. Chem. Soc. Jpn., vol. 71, No. 5, pp. 1125-1135 (1998).
Abstract of Piras et al., Farmaco, vol. 48, pp. 1249-1259 (1993).
Abstract of Collins et al., Bioorg. Med. Chem. Lett., vol. 2, No. 9, pp. 915-918 (1992).
Abstract of Shinde et al., Indian Drugs, vol. 27, pp. 32-34 (1989).
Abstract of Iijima et al., Chem. Pharm. Bull., vol. 37, No. 3, pp. 618-620 (1989).
Abstract of Mahajanshetti et al., Indian J. Chem., vol. 12, No. 1, pp. 54-56 (1974).

Affiliated with

Also associated with

Rating

Non-peptide GLP-1 agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-peptide GLP-1 agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-peptide GLP-1 agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3508564